Keywords: orphan, medical, work, iv, busulfan, division, company

ORPHAN MEDICAL TO WORK ON IV BUSULFAN

Article | 28 February 1994

Print This

The Orphan Medical division of US company Chronimed has acquired an exclusive worldwide licensing agreement with the MD Anderson Cancer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in